| Name | Affiliation |
|---|---|
| Anthony Atkinson | London School of Economics |
| Barbara Bogacka | Queen Mary, University of London |
| Eva Bouguen | I.R.I. Servier, France |
| Dankmar Böhning | University of Reading |
| Abderrahmane Bourredjem | Institut Gustave-Roussy, France |
| Claire Brittain | Eli Lilly |
| Yen Chuah | Quintiles |
| Nigel Dallow | GlaxoSmithKline |
| Maria Efstathiou | Quintiles |
| Monia Ezzalfani | Institut Gustave-Roussy, France |
| Jing Jin | London School of Hygiene and Tropical Medicine |
| Thomas Hamborg | University of Warwick |
| Lisa Hamilton | Amgen |
| Siew Wan Hee | University of Warwick |
| Dominik Heinzmann | F. Hoffmann-La Roche AG, Switzerland |
| Shu-Fang Hsu Schmitz | Swiss Group for Clinical Cancer Research |
| Paul Jordan | F. Hoffmann-La Roche AG, Switzerland |
| Andreas Kaiser | Bayer Schering Pharma AG, Germany |
| Peter Kimani | University of Warwick |
| Nelson Kinnersley | Roche Products Limited |
| Stefan Klein | Bayer Schering Pharma AG, Germany |
| Marie-Cécile Le Deley | Institut Gustave-Roussy, France |
| Audrey Mauguen | Institut Gustave-Roussy, France |
| Georgina Meneses-Lorente | Roche Products Limited |
| Shahrul Mt-Isa | Imperial College London |
| Markus Niggli | F. Hoffmann-La Roche AG, Switzerland |
| Ken Nip | Takeda Global R & D |
| Eamonn O'Brien | Almac Diagnostics |
| Emma O'Connor | Eli Lilly |
| Deepak Parashar | Cambridge Cancer Trials Centre |
| Katy Pelling | Boehringer Ingelheim Limited |
| Sylvie Retout | Roche SAS, France |
| Maria Roopa | Queen Mary, University of London |
| Annette Sauter | F. Hoffmann-La Roche AG, Switzerland |
| Matthias Stölzel | Astellas Pharma Global Development, The Netherlands |
| Michael Sweeting | MRC Biostatistics Unit |
| Edward Waldron | Takeda Global R & D |
| James Wason | MRC Biostatistics Unit |
| Brandon Whitcher | GlaxoSmithKline |
| Eric Worth | Roche Products Limited |
| Ann Yellowlees | Quantics Consulting Limited |
| Wai Yin Yeung | Queen Mary, University of London |